Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Independent Advisor Alliance

Independent Advisor Alliance increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 19.8% during the fourth quarter, Holdings Channel.com reports. The fund owned 3,006 shares of the biotechnology company’s stock after acquiring an additional 497 shares during the quarter. Independent Advisor Alliance’s holdings in Axon Enterprise were worth $1,787,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Asset Dedication LLC grew its stake in Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its position in Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares in the last quarter. Venturi Wealth Management LLC increased its stake in Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after buying an additional 21 shares during the period. Insigneo Advisory Services LLC lifted its position in Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC boosted its stake in shares of Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

AXON has been the topic of a number of research reports. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Activity

In related news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jeffrey C. Kunins sold 1,370 shares of the business’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $639.14, for a total transaction of $875,621.80. Following the completion of the transaction, the insider now owns 125,950 shares in the company, valued at approximately $80,499,683. This trade represents a 1.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,146 shares of company stock worth $3,262,847. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Down 4.2 %

Shares of AXON opened at $534.56 on Friday. The stock’s 50-day moving average price is $595.56 and its 200 day moving average price is $532.90. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The firm has a market capitalization of $40.96 billion, a price-to-earnings ratio of 138.13, a P/E/G ratio of 5.17 and a beta of 1.12.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.